A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy-Reference-Cited by-同舟云学术

A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

Published:2003-01 Issue:1 Volume:14 Page:29-35
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Green M.D.,Koelbl H.,Baselga J.,Galid A.,Guillem V.,Gascon P.,Siena S.,Lalisang R.I.,Samonigg H.,Clemens M.R.,Zani V.,Liang B.C.,Renwick J.,Piccart M.J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/1/29/302428/mdg019.pdf

Reference16 articles.

1. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia;Bodey;Ann Intern Med,1966

2. The effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium;Gabrilove;N Engl J Med,1988

3. Effects of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy;Morstyn;Lancet,1988

4. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer;Crawford;N Engl J Med,1991

5. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy;Trillet-Lenoir;Eur J Cancer,1993

Cited by 519 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer;BMC Cancer;2024-09-13

2. Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma;New England Journal of Medicine;2024-09-05

3. Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study;YAKUGAKU ZASSHI;2024-09-01

4. Mecapegfilgrastim for the prophylaxis of chemotherapy‐induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study;Head & Neck;2024-08-11

5. Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer;International Journal of Clinical Oncology;2024-07-15